XML 53 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting - Schedule of Operating Expenses of Our Clinical Stage Drug Development Segment (Details) - CODM [Member] - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Clinical Study Expense $ 7,960,600 $ 3,172,600
Other Research Expense 1,831,000 7,066,900
Manufacturing and Drug Storage Expense 155,600 292,500
Pre-clinical Expense 33,700
Compensation Expense 933,500 1,040,300
Stock-based Compensation Expense 1,070,300 1,699,300
Total Research and Development Expense $ 11,951,000 $ 13,305,300